Athersys, Inc.
Industry
- Biotechnology
- Gene Therapy, Cell Therapy
- Drug Discovery Technologies
- Pharmaceuticals
Other Names/Subsidiaries
- BTHC VI
- ReGenesys
- ABT Holding Company
Latest on Athersys, Inc.
Regenerative medicine-focused Japanese biotech Healios K.K. has acquired its long-time US collaborator Athersys, Inc. in a move that will give it access to multiple assets and technologies. The $2
Drug developers and investors left San Francisco after the recent J.P. Morgan Healthcare Conference feeling optimistic about prospects for returns on biopharmaceutical investments, certain that forthc
The Biotech Patient In one of David Poyer’s novels on the career of a fictional US naval officer, a regional war erupts and politicians consult with academics on how such conflicts are resolved. While
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Maruho Obtains Rights To GI-301 No